SCHEMBL7309489

SCHEMBL7309489

CC1(C)O[C@@H]([C@@H](Cc2ccccc2)OS(C)(=O)=O)[C@H]([C@@H](Cc2ccccc2)OS(C)(=O)=O)O1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ANPEP P15144 1/20 0.35
LAP3 P28838 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
CYP24A1 Q07973 1/20 0.33
PTGES2 Q9H7Z7 1/20 0.33
SLC6A2 P23975 2/20 0.33
TAAR1 Q96RJ0 2/20 0.33
MAOA P21397 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
CYP2A6 P11509 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
PTPN1 P18031 1/20 0.32
CDC25A P30304 1/20 0.32
DUSP3 P51452 1/20 0.32
CYP3A4 P08684 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7306681 0.84 HTR2A (0.41) SLC6A2SLC6A4SLC6A3SIGMAR1CYP2A6
SCHEMBL8531804 0.80 HTT (0.41) MEN1KMT2ACYP1A2MMP2
SCHEMBL27489574 0.75 MEN1 (0.35) MEN1KMT2ACYP24A1PTGES2SLC6A2
SCHEMBL27489575 0.75 MEN1 (0.35) MEN1KMT2ACYP24A1PTGES2SLC6A2
SCHEMBL7987728 0.73 TAAR1 (0.43) LAP3MEN1KMT2ACYP24A1PTGES2
SCHEMBL1988591 0.73 HTT (0.35) MEN1KMT2ACYP3A4MMP2
SCHEMBL3589541 0.72 TAAR1 (0.47) MEN1KMT2APTGES2SLC6A2TAAR1
SCHEMBL21378558 0.72 TAAR1 (0.47) MEN1KMT2APTGES2SLC6A2TAAR1
SCHEMBL22441312 0.72 TAAR1 (0.47) MEN1KMT2APTGES2SLC6A2TAAR1
SCHEMBL7306087 0.71 CYP3A4 (0.38) ANPEPCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0575097-B1 2,3-Bis-carboxamidomethyl substituted oxiranes as inhibitors of HIV protease and their use for the treatment of AIDS LILLY CO ELI (US) 2000-11-02 EP disclosed
US-5578608-A HIV PROTEASE INHIBITOR ELI LILLY AND COMPANY (US) 1996-11-26 US disclosed
EP-0652009-A1 Identification and use of protease inhibitors ELI LILLY AND COMPANY (US) 1995-05-10 EP disclosed
EP-0575097-A1 2,3-Bis-carboxamidomethyl substituted oxiranes as inhibitors of HIV protease and their use for the treatment of AIDS ELI LILLY AND COMPANY (US) 1993-12-22 EP disclosed